Armstrong, Fleming & Moore, Inc Novo Nordisk A S Transaction History
Armstrong, Fleming & Moore, Inc
- $144 Billion
- Q1 2024
A detailed history of Armstrong, Fleming & Moore, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Armstrong, Fleming & Moore, Inc holds 4,658 shares of NVO stock, worth $646,856. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,658
Previous 4,658
-0.0%
Holding current value
$646,856
Previous $482 Million
24.12%
% of portfolio
0.41%
Previous 0.36%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,859Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.93 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.91 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.81 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.67 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.64 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $313B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...